King Pharmaceuticals KG Legacy Reinsurance — Net premiums written
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's legacy reinsurance — net premiums written.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's legacy reinsurance — net premiums written?
- King Pharmaceuticals (KG) reported legacy reinsurance — net premiums written of $2.65M in Q1 2026.
- What does legacy reinsurance — net premiums written mean?
- Represents the gross premiums written by the legacy reinsurance segment minus the portion ceded to other reinsurers. This figure provides a clearer view of the risk the segment retains on its own balance sheet.